Pulmonary Hypertension in Sickle Cell Disease: Acute or Chronic Complication?

Authors

  • A. Jamoussi Faculté de médecine de Tunis, université de Tunis El Manar
  • T. Merhabene Faculté de médecine de Tunis, université de Tunis El Manar
  • H. Neji Faculté de médecine de Tunis, université de Tunis El Manar
  • K. Ayed Faculté de médecine de Tunis, université de Tunis El Manar
  • J. Ben Khelil Faculté de médecine de Tunis, université de Tunis El Manar
  • M. Besbes Faculté de médecine de Tunis, université de Tunis El Manar

DOI:

https://doi.org/10.3166/rea-2019-0097

Keywords:

Cardiac arrest, Sudden cardiac death, Percutaneous coronary intervention

Abstract

Introduction: During sickle cell disease, pulmonary hypertension is common and worsens prognosis. Its diagnosis in time is mandatory.

Case reports: The first case reported chronic pulmonary hypertension that impacts respiratory function. It was suspected during an acute exacerbation which was then confirmed later. The second case described an acute pulmonary hypertension concomitant with an acute chest syndrome that recovered spontaneously after the acute episode resolution.

Conclusions: Pulmonary hypertension noticed within an acute exacerbation of sickle cell disease can be acute and reversible or chronic and permanent. A delayed exploration of the right cardiac function is necessary to plan appropriate monitoring.

Published

2019-07-01

How to Cite

Jamoussi, A., Merhabene, T., Neji, H., Ayed, K., Ben Khelil, J., & Besbes, M. (2019). Pulmonary Hypertension in Sickle Cell Disease: Acute or Chronic Complication?. Médecine Intensive Réanimation, 28(4), 339–342. https://doi.org/10.3166/rea-2019-0097